Financhill
Back

Immunovant, Inc. 10K Form

Sell
37

IMVT
Immunovant, Inc.

Last Price:
$22.86
Seasonality Move:
-10.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMVT News And Ratings

See the #1 stock for the next 7 days that we like better than IMVT

IMVT Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-102.5M
Price / Cash Flow: 0
Annual Sales: $2.98
Price / Book: 7.7

Profitability

EPS (TTM): -2.82910
Net Income (TTM): $-464.7M
Gross Margin: $-377K
Return on Equity: -88.1%
Return on Assets: -78.54%

Immunovant, Inc. Earnings Forecast

Key Immunovant, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 1 years.

Immunovant, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMVT
CUSIP: 45258J
Website: immunovant.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.07
Quick Ratio: 8.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMVT Technical Analysis vs Fundamental Analysis

Sell
37
Immunovant, Inc. (IMVT) is a Sell

Is Immunovant, Inc. a Buy or a Sell?

  • Immunovant, Inc. stock is rated a Sell
    The current Immunovant, Inc. [IMVT] share price is $22.84. The Score for IMVT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.